These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15809132)

  • 1. Anesthesia in the obese patient: pharmacokinetic considerations.
    Casati A; Putzu M
    J Clin Anesth; 2005 Mar; 17(2):134-45. PubMed ID: 15809132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative pharmacology in morbid obesity.
    Lemmens HJ
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):485-91. PubMed ID: 20531173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Distribution in Obesity and following Bariatric Surgery: A Literature Review.
    Macgregor AM; Boggs L
    Obes Surg; 1996 Feb; 6(1):17-27. PubMed ID: 10731246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of obesity on pharmacokinetics implications for drug therapy.
    Cheymol G
    Clin Pharmacokinet; 2000 Sep; 39(3):215-31. PubMed ID: 11020136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity modestly affects inhaled anesthetic kinetics in humans.
    Lemmens HJ; Saidman LJ; Eger EI; Laster MJ
    Anesth Analg; 2008 Dec; 107(6):1864-70. PubMed ID: 19020131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol clearance in morbidly obese children and adolescents: influence of age and body size.
    Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA
    Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic changes in obesity].
    Girardin E; Bruguerolle B
    Therapie; 1993; 48(4):397-402. PubMed ID: 8128423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of drugs in obesity. An update.
    Cheymol G
    Clin Pharmacokinet; 1993 Aug; 25(2):103-14. PubMed ID: 8403734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing dilemmas in obese children.
    Mulla H; Johnson TN
    Arch Dis Child Educ Pract Ed; 2010 Aug; 95(4):112-7. PubMed ID: 20585055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desflurane versus sevoflurane for maintenance of outpatient anesthesia: the effect on early versus late recovery and perioperative coughing.
    White PF; Tang J; Wender RH; Yumul R; Stokes OJ; Sloninsky A; Naruse R; Kariger R; Norel E; Mandel S; Webb T; Zaentz A
    Anesth Analg; 2009 Aug; 109(2):387-93. PubMed ID: 19608808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial dosing considerations in obese adult patients.
    Pai MP; Bearden DT
    Pharmacotherapy; 2007 Aug; 27(8):1081-91. PubMed ID: 17655508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Should the dosage of fentanyl be based on the body weight when the patient is obese? A proposal of the appropriate "pharmacokinetic body mass"].
    Masui; 2004 Dec; 53 Suppl():S145-52. PubMed ID: 15672745
    [No Abstract]   [Full Text] [Related]  

  • 15. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
    Pai MP
    Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
    Schmitt A; Gladieff L; Lansiaux A; Bobin-Dubigeon C; Etienne-Grimaldi MC; Boisdron-Celle M; Serre-Debauvais F; Pinguet F; Floquet A; Billaud E; Le Guellec C; Penel N; Campone M; Largillier R; Capitain O; Fabbro M; Houede N; Medioni J; Bougnoux P; Lochon I; Chatelut E
    Clin Cancer Res; 2009 May; 15(10):3633-9. PubMed ID: 19401344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent depression of contractility and vasodilation with propofol but not with sevoflurane or desflurane in rabbits.
    Royse CF; Liew DF; Wright CE; Royse AG; Angus JA
    Anesthesiology; 2008 Jan; 108(1):87-93. PubMed ID: 18156886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative.
    Spinler SA; Ou FS; Roe MT; Gibler WB; Ohman EM; Pollack CV; Alexander KP; Peterson ED
    Pharmacotherapy; 2009 Jun; 29(6):631-8. PubMed ID: 19476416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients.
    La Colla L; Albertin A; La Colla G; Ceriani V; Lodi T; Porta A; Aldegheri G; Mangano A; Khairallah I; Fermo I
    Eur J Anaesthesiol; 2009 May; 26(5):362-9. PubMed ID: 19307972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.